Atea Pharmaceuticals re-elects two Class I directors; Berger receives 48% withhold votes

Atea Pharmaceuticals, Inc.

Franklin Berger elected with 30.5M for, 28.3M withheld (48% withhold); Sommadossi elected with 40.8M for, 18.1M withheld.
KPMG LLP ratified as auditor for FY2024: 62.3M for, 6.5M against, 5.6M abstain.
Say-on-pay proposal approved on advisory basis: 42.9M for, 15.5M against, 0.4M abstain.
88.3% of outstanding shares voted (74.4M of 84.3M shares).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.